Search
for
Sort by
Research 241–270 of 1000+
- Alopecia and its medical management
- Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto
- Encapsulación en ciclodextrinas de compuestos con actividad frente a la alopecia androgénica masculina.
- Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata
- Finasteride en el año 2006
- Pharmacological Effects of the Lipidosterolic Extract from Kigelia africana Fruits in Experimental Benign Prostatic Hyperplasia Induced by Testosterone in Sprague Dawley Rats
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases
- 875 Clinical, Histologic and Immunohistochemical Characterization of Mixed Epithelial and Stromal Tumor of the Seminal Vesicle: A Systematic Review and a Novel Case Report
- Extensive Challenges and Pending Advances in the Study of 5-Alpha-Reductase Isoenzymes. A Literature Review
- Platelet-Rich Plasma à la Carte
- Recent Status of Procedures in a Single Nationwide Cosmetic Surgery Group
- Effect of N-acetylcysteine on hair follicle changes in mouse model of cyclophosphamide-induced alopecia: histological and biochemical study
- Knowledge Mapping of Drug Repositioning’s Theme and Development
- Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem)
- Overnight loss of pigmented hair in autoimmune autonomic neuropathy treated with IVIg
- Are We Ready to Measure Skin Permeation of Modern Antiaging GHK–Cu Tripeptide Encapsulated in Liposomes?
- Advancements in Drug Repurposing: Examples in Psychiatric Medications
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- Solubilizing steroidal drugs by β-cyclodextrin derivatives
- Recent advances in treatment for Benign Prostatic Hyperplasia
- Exploring the efficacy of testosterone undecanoate in male children with 5α‐reductase deficiency
- Staphylococcus epidermidis Cicaria, a Novel Strain Derived from the Human Microbiome, and Its Efficacy as a Treatment for Hair Loss
- Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement
- SAT340 Matters Of The HAART - Ritonavir Induced CYP3A4 Inhibition of Intranasal Fluticasone Leading To Cushing’s Syndrome
- The Excesses of Cosmetic Medicine
- Evaluation of Dutasteride-Loaded Liposomes and Transfersomes for Follicular-Targeting for Androgenic Alopecia Topical Treatment
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Temperature-responsive detachable microneedles integrated with minoxidil nanoparticle for effectively promoting hair regrowth